title: [Surgical treatment of pancreatic carcinoma: problems and recent advances].
abstract: Nowadays surgical technologies develop fast under the guidance of minimally invasive medicine, evidence-based medicine, multi-disciplinary team and other ideas. However, the long-term outcome of pancreatic cancer remains dismal. In addition to the improvement of surgical resection rate, more attention should be paid to improve the overall survival rate of the patients with pancreatic cancer after surgery. Clinical studies of neoadjuvant therapies for the treatment of borderline resectable pancreatic cancer are advocated. Various types of pancreaticojejunostmy should be applied individually to improve the anastomosis quality and to reduce the postoperative complications. In the system of precision medicine, standardized surgical treatment pattern remains important.
authors.affiliation: Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
authors.forename: Y M
authors.initials: YM
authors.lastname: Yang
authors.forename: Y P
authors.initials: YP
authors.lastname: Zhao
mesh_terms: D021441:Carcinoma, Pancreatic Ductal / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D059248:Chemoradiotherapy; D002681:China / Q000453:epidemiology; D019317:Evidence-Based Medicine; D006801:Humans; D020360:Neoadjuvant Therapy; D010180:Pancreatectomy / Q000379:methods* / Q000592:standards; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D010193:Pancreaticojejunostomy / Q000379:methods / Q000592:standards; D011183:Postoperative Complications / Q000453:epidemiology; D057285:Precision Medicine; D015996:Survival Rate; D016896:Treatment Outcome